Medicare Enrolled
Dr. Miguel Albino, MD
Medical Oncology · Austin, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Albino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Albino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Albino
Dr. Miguel Albino is a medical oncology specialist in Austin, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Albino performed 71,035 Medicare services across 2,079 unique beneficiaries.
Between the years covered by Open Payments, Dr. Albino received a total of $298,314 from 48 pharmaceutical and/or device companies across 575 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Albino is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 14% volume in TX
$298,314 industry payments
Medicare Practice Summary
Medicare Utilization ↗71,035
Medicare services
Top 14% in TX for medical oncology
2,079
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,440 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
17,400 | $0 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
17,100 | $0 | $2 |
| Paclitaxel chemotherapy injection | 10,974 | $0 | $8 |
| Pembrolizumab injection (Keytruda) | 9,300 | $43 | $137 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
4,470 | $23 | $155 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,280 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,430 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 970 | $0 | $24 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
587 | $13 | $108 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
514 | $2 | $300 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
510 | $6 | $28 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 500 | $3 | $373 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
454 | $1 | $6 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
413 | $8 | $36 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
404 | $107 | $707 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
398 | $93 | $368 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
383 | $8 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
348 | $10 | $64 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
286 | $24 | $157 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
168 | $53 | $344 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
150 | $52 | $313 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
147 | $2 | $19 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
133 | $2 | $13 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
130 | $1 | $7 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
129 | $23 | $161 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
120 | $6 | $431 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
104 | $11 | $96 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
90 | $60 | $211 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
73 | $16 | $100 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
72 | $27 | $145 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
72 | $1 | $8 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
71 | $10 | $75 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
66 | $26 | $256 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
61 | $35 | $143 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
57 | $13 | $60 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
57 | $9 | $56 |
| Iron level test | 57 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
57 | $9 | $35 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
47 | $6 | $31 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
38 | $17 | $60 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
38 | $19 | $114 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $91 | $357 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
33 | $46 | $289 |
| Injection, lorazepam, 2 mg | 29 | $1 | $3 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
26 | $16 | $94 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
26 | $1 | $19 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $138 | $496 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
20 | $74 | $264 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $125 | $565 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $58 | $250 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
18 | $4 | $23 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
17 | $11 | $99 |
| Immunologic analysis of serum A laboratory test that uses immunologic techniques to analyze components in a blood serum sample. |
16 | $29 | $108 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
16 | $22 | $160 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
15 | $1,205 | $4,802 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 15 | $90 | $657 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
14 | $31 | $58 |
| New patient office visit, complex (60-74 min) | 13 | $175 | $709 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
12 | $76 | $171 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $99 | $470 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.9% high complexity
94.8% medium
3.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$298,314
Total received (2018-2024)
Avg $42,616/year across 7 years
Top 6% in TX for medical oncology
48
Companies
575
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$279,788 (93.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,110 (4.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,416 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$41,423
2023
$87,138
2022
$41,904
2021
$32,308
2020
$12,654
2019
$44,955
2018
$37,932
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$102,907
Takeda Pharmaceuticals U.S.A., Inc.
$88,464
Gilead Sciences, Inc.
$70,406
Amgen Inc.
$12,121
EMD Serono, Inc.
$6,883
Novocure Inc.
$5,794
Eli Lilly Export S.A. Puerto Rico Branch
$3,856
Daiichi Sankyo Inc.
$1,157
Immunomedics, Inc.
$1,060
Janssen Biotech, Inc.
$1,031
E.R. Squibb & Sons, L.L.C.
$890
Incyte Corporation
$514
AstraZeneca Pharmaceuticals LP
$381
GENZYME CORPORATION
$249
Tempus AI, Inc
$242
Novartis Pharmaceuticals Corporation
$231
PFIZER INC.
$225
Regeneron Healthcare Solutions, Inc.
$189
Secura Bio, Inc.
$184
Medtronic, Inc.
$148
Karyopharm Therapeutics Inc.
$139
Merck Sharp & Dohme LLC
$134
Sirtex Medical Inc
$124
Celgene Corporation
$120
Intera Oncology, Inc
$107
Mirati Therapeutics, Inc.
$72
Janssen Pharmaceuticals, Inc
$60
Seagen Inc.
$57
Astellas Pharma US Inc
$56
Alexion Pharmaceuticals, Inc.
$51
Coherus Biosciences Inc.
$51
Deciphera Pharmaceuticals Inc.
$48
Kite Pharma, Inc.
$36
GlaxoSmithKline, LLC.
$33
ABBVIE INC.
$30
Genmab U.S., Inc.
$26
TAIHO ONCOLOGY, INC.
$24
Immunocore Limited
$24
Apellis Pharmaceuticals, Inc.
$23
BeiGene USA, Inc.
$23
Myriad Genetic Laboratories, Inc.
$22
Janssen Scientific Affairs, LLC
$22
Puma Biotechnology, Inc.
$21
Sumitomo Pharma America, Inc.
$21
ARRAY BIOPHARMA INC
$17
Agios Pharmaceuticals, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$16
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 87.8% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · AUGTYRO · BAVENCIO · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CYRAMZA · DARZALEX · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · ERLEADA · Empaveli · Enhertu · Epkinly · FARYDAK · Fabhalta · IMBRUVICA · IMFINZI · INLYTA · INTERA · JEVTANA · KEYTRUDA · KIMMTRAK · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · MEKINIST · MYRISK · Nplate · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PLUVICTO · PROMACTA · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · SARCLISA · SCEMBLIX · SIGNIA · SIR-Spheres Microspheres · TAGRISSO · TECVAYLI · TRODELVY · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Vectibix · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for medical oncology in TX.
Equivalent to $420 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
28
Per 100K population
2.1
County median income
$97,169
Nearest hospital
NORTH AUSTIN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Albino is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), with speaking/promotional industry engagement in the top 6% of TX peers, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Albino experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Albino performed 17,400 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Albino receive payments from pharmaceutical companies?
Yes. Dr. Albino received a total of $298,314 from 48 companies across 575 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Albino's costs compare to other medical oncologists in Austin?
Dr. Albino's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Albino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Austin
Browse medical oncologists in Austin ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology